DYRK1A and Alzheimer disease: Finally, DYRK1A is overexpressed in individuals with T21 and AD compared to AD by several-fold increase, measured as the number of DYRK1A-positive NFTs in human T21/AD brain compared to human AD brain tissue samples (Wegiel et al., 2008).